Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.28) by 25 percent. This is a 10.26 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $42.000 thousand which missed the analyst consensus estimate of $70.000 thousand by 40.00 percent. This is a 25.00 percent decrease over sales of $56.000 thousand the same period last year.